Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services crawled date : 2023 - 01 - 04 save search
Century Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-04 (Crawled : 21:00) - biospace.com/
IPSC | $2.975 4.75% 4.38% 150K
|
Professional, Scientific, and T...
|
| O: 0.4%
H: 1.2%
C: -0.4%
conference therapeutics
Global Legionella Testing Market 2023-2027
Published: 2023-01-04 (Crawled : 16:00) - prnewswire.com
IKTSY | $59.97 -0.47% -12.21% 0
|
Professional, Scientific, and T...
|
| O: 1.67%
H: 0.84%
C: -0.16%
TMO | News | $541.52 -1.05% 0.0% 5.4K
|
Health Technology
|
| O: 1.11%
H: 1.52%
C: 0.47%
global market
Biomea Fusion Announces Dosing of First Patient with Type 2 Diabetes in the United States in Ongoing Phase I/II (COVALENT-111) Study of BMF-219
Published: 2023-01-04 (Crawled : 15:00) - biospace.com/
BMEA | $11.16 -2.96% -2.86% 6
|
Professional, Scientific, and T...
|
| O: 2.0%
H: 0.0%
C: -11.45%
alent-111 ongoing bmf-219 diabetes study
Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors
Published: 2023-01-04 (Crawled : 15:00) - biospace.com/
ABOS | $3.16 -8.93% -9.12% 640K
|
Professional, Scientific, and T...
|
| O: -1.33%
H: 7.32%
C: 5.2%
pharmaceuticals
Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
Published: 2023-01-04 (Crawled : 14:20) - biospace.com/
CYTH | $1.2 -0.83% 0.82% 0
|
Professional, Scientific, and T...
|
| O: 4.45%
H: 3.83%
C: 3.83%
metabolic meeting therapeutics presentation
OMNIQ’S Q SHIELD™ AI-BASED SAFE CITY SYSTEM, TO BE DEPLOYED IN TWO ADDITIONAL CITIES IN IOWA BRINGING THE TOTAL NUMBER OF CITIES TO 16
Published: 2023-01-04 (Crawled : 14:00) - globenewswire.com
OMQS | News | $0.5374 -13.0% -16.77% 500K
|
Professional, Scientific, and T...
|
| O: 1.75%
H: 2.65%
C: -16.3%
Alzamend Neuro Partners With Biorasi to Conduct a First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Phase I/IIA Clinical Trial
Published: 2023-01-04 (Crawled : 14:00) - biospace.com/
ALZN | $0.691 -4.57% -4.79% 130
|
Professional, Scientific, and T...
|
| O: 3.45%
H: 0.0%
C: -3.35%
trial group
Monte Rosa Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-04 (Crawled : 13:00) - globenewswire.com
GLUE | $5.92 2.07% 2.19% 50
|
Professional, Scientific, and T...
|
| O: 1.03%
H: 0.0%
C: -1.4%
conference rosa therapeutics
Insights on the Efficacy Testing Global Market to 2030 - Increasing Concerns Over Product Stability Drives Growth
Published: 2023-01-04 (Crawled : 12:20) - prnewswire.com
IKTSY | $59.97 -0.47% -12.21% 0
|
Professional, Scientific, and T...
|
| O: 1.67%
H: 0.84%
C: -0.16%
SHC | $10.9 1.4% 1.29% 710K
|
Commercial Services
|
| O: 1.92%
H: 1.41%
C: -0.47%
global growth market
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K
|
EGOX | $0.036 12.15% 31.56% 32M
|
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
TPET | $0.3279 -3.56% 23.57% 11M
|
n/a
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.